Recent Publications

FY2020 Article Publications by City of Hope Authors

(October to December)


Library Services attempted to include all article publications published during this reporting period to the best of our ability. If your article is missing, please alert us by sending an email to with the subject “Missing publication”. We will investigate the publication and get back to you as soon as possible, as well as include it in the next reporting period.

Not all publications are freely available or available via our print and online collections. For those publications you are unable to access, please submit a request via ILLiad, our online document delivery and interlibrary loan system, and Library Services will fill it as soon as possible.

  1. Raoof, M., Blakely, A.M., Melstrom, L.G., Lee, B., Warner, S.G., Chung, V., Singh, G., Chen, Y.J., & Fong, Y. (2019). Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis. Cancer Med, 8(13), 5881-90.
  2. Sweeney, F.C., Demark-Wahnefried, W., Courneya, K.S., Sami, N., Lee, K., Tripathy, D., Yamada, K., Buchanan, T.A., Spicer, D.V., Bernstein, L., Mortimer, J.E., & Dieli-Conwright, C.M. (2019). Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial. Phys Ther, 99(10), 1334-45.
  3. Ambinder, R.F., Wu, J., Logan, B., Durand, C.M., Shields, R., Popat, U.R., Little, R.F., McMahon, D.K., Cyktor, J., Mellors, J.W., Ayala, E., Kaplan, L.D., Noy, A., Jones, R.J., Howard, A., Forman, S.J., Porter, D., Arce-Lara, C., Shaughnessy, P., Sproat, L., Hashmi, S.K., Mendizabal, A.M., Horowitz, M.M., Navarro, W.H., & Alvarnas, J.C. (2019). Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial. Biol Blood Marrow Transplant, 25(11), 2160-6.
  4. Ustun, C., Le-Rademacher, J., Wang, H.L., Othus, M., Sun, Z.X., Major, B., Zhang, M.J., Storrick, E., Lafky, J.M., Chow, S., Mrozek, K., Attar, E.C., Nand, S., Bloomfield, C.D., Cripe, L.D., Tallman, M.S., Appelbaum, F., Larson, R.A., Marcucci, G., Roboz, G.J., Uy, G.L., Stone, R.M., Jatoi, A., Shea, T.C., de Lima, M., Foran, J.M., Sandmaier, B.M., Litzow, M.R., Erba, H.P., Hurria, A., Weisdorf, D.J., & Artz, A.S. (2019). Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. Leukemia, 33(11), 2599-609.
  5. Herrera, A.F., Chen, L., Khajavian, S., Chase, M., Darrah, J., Maloney, D., Ho, V.T., Soiffer, R.J., Antin, J.H., Forman, S.J., Nademanee, A.P., Chen, Y.B., Armand, P., & Shadman, M. (2019). Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma. Biol Blood Marrow Transplant, 25(12), 2383-7.
  6. Rich, T.A., Reckamp, K.L., Chae, Y.K., Doebele, R.C., Iams, W.T., Oh, M., Raymond, V.M., Lanman, R.B., Riess, J.W., Stinchcombe, T.E., Subbiah, V., Trevarthen, D.R., Fairclough, S., Yen, J., & Gautschi, O. (2019). Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations. Clin Cancer Res, 25(19), 5832-42.
  7. Parikh, A.R., He, Y.T., Hong, T.S., Corcoran, R.B., Clark, J.W., Ryan, D.P., Zou, L., Ting, D.T., Catenacci, D.V., Chao, J., Fakih, M., Klempner, S.J., Ross, J.S., Frampton, G.M., Miller, V.A., Ali, S.M., & Schrock, A.B. (2019). Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy. Oncologist, 24(10), 1340-7.
  8. Gao, Y., Xi, H., Wei, B., Cui, J., Zhang, K., Li, H., Cai, A., Shen, W., Li, J., Rosell, R., Chao, J., Chen, T., Klempner, S., Qiao, Z., & Chen, L. (2019). Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis. Front Oncol, 9, Article number: 1222.
  9. Apprey, V., Wang, S.P., Tang, W., Kittles, R.A., Southerland, W.M., Ittmann, M., & Kwabi-Addo, B. (2019). Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity. Anticancer Res, 39(11), 5861-6.
  10. Coy, H., Young, J.R., Pantuck, A.J., Douek, M.L., Sisk, A., Magyar, C., Brown, M.S., Sayre, J., & Raman, S.S. (2019). Association of tumor grade, enhancement on multiphasic CT and microvessel density in patients with clear cell renal cell carcinoma. Abdom Radiol (NY).
  11. Kowolik, C.M., Lin, M., Xie, J., Overman, L.E., & Horne, D.A. (2019). Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer. J Exp Clin Cancer Res, 38, Article number: 431.
  12. Cohen, S.A. (2019). The AUA Curriculum for Medical Students: Current Resources and Developments. Current Urology Reports, 20, 86.
  13. Adams, C.D., & Neuhausen, S.L. (2019). Bi-directional Mendelian randomization of epithelial ovarian cancer and schizophrenia and uni-directional Mendelian randomization of schizophrenia on circulating 1- or 2-glycerophosphocholine metabolites. Mol Genet Metab Rep, 21, 100539.
  14. Rambaldi, A., Ribera, J.M., Kantarjian, H.M., Dombret, H., Ottmann, O.G., Stein, A.S., Tuglus, C.A., Zhao, X., Kim, C., & Martinelli, G. (2019). Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Cancer, 126(2), 304-10.
  15. Chen, Q.C., Deng, X.L., Hu, X.Y., Guan, S., He, M., Wang, Y.L., Wei, B.B., Zhang, J., Zhao, H.S., Yao, W.F., Jin, F., Liu, Y., Chen, J.J., Olapade, O.I., Wu, H.Z., & Wei, M.J. (2019). Breast Cancer Risk-Associated SNPs in the mTOR Promoter Form De Novo KLF5-and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. Mol Cancer Res, 17(11), 2244-56.
  16. Bergerot, P., Lamb, P., Wang, E., & Pal, S.K. (2019). Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence. Mol Cancer Ther, 18(12), 2185-93.
  17. Pal, S., Hu-Lieskovan, S., & Agarwal, N. (2019). Can pegylated IL-10 add to a backbone of PD-1 inhibition for solid tumours? The Lancet Oncology, 20(11), 1473-4.
  18. DeSantis, C.E., Miller, K.D., Dale, W., Mohile, S.G., Cohen, H.J., Leach, C.R., Goding Sauer, A., Jemal, A., & Siegel, R.L. (2019). Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin, 69(6), 452-67.
  19. Sun, V., Bojorquez, O., Grant, M., Wendel, C.S., Weinstein, R., & Krouse, R.S. (2019). Cancer survivors' challenges with ostomy appliances and self-management: a qualitative analysis. Support Care Cancer.
  20. Wang, C.K., Sandhu, J., & Fakih, M. (2019). A case of class 3 MEK1 mutated metastatic colorectal cancer with a non-durable tumor marker response to MEK and ERK inhibitors. J Gastrointest Oncol, 10(6), 1140-3.
  21. Chen, J., Ngo, D., & Rosenthal, J. (2019). Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease. J Oncol Pharm Pract, 25(8), 2027-30.
  22. Shao, M., Wang, Q.A., Song, A., Vishvanath, L., Busbuso, N.C., Scherer, P.E., & Gupta, R.K. (2019). Cellular Origins of Beige Fat Cells Revisited. Diabetes, 68(10), 1874-85.
  23. Solorzano-Vargas, R.S., Bjerknes, M., Wu, S.V., Wang, J., Stelzner, M., Dunn, J.C.Y., Dhawan, S., Cheng, H., Georgia, S., & Martin, M.G. (2019). The cellular regulators PTEN and BMI1 help mediate NEUROGENIN-3-induced cell cycle arrest. J Biol Chem, 294(41), 15182-92.
  24. Sampath, S., Rahmanuddin, S., Sahoo, P., Frankel, P., Boswell, S., Wong, J., Rotter, A., Rockne, R., Wong, J., & Park, J.M. (2019). Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial. Int J Radiat Oncol Biol Phys, 105(3), 659-63.
  25. Mortimer, J.E., Kruper, L., Jung, J., Wong, L., Cooper, J., Stewart, D., Chung, S., Yu, K.W., Dadwal, S., & Yuan, Y. (2019). Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab. Cancer Chemother Pharmacol.
  26. Hurley, S., Goldberg, D., Von Behren, J., Clague DeHart, J., Wang, S., & Reynolds, P. (2019). Chronotype and postmenopausal breast cancer risk among women in the California Teachers Study. Chronobiol Int, 36(11), 1504-14.
  27. Mayadevi, L., Geetha Kumary, B.S., Sudam, M.W., Abdulla, F., Veerabhadran, B., Muralee, M., Rahuman, S.A., George, P.S., Chandramohan, K., & Grant, M. (2019). The City of Hope Quality of Life Stoma Questionnaire: Malayalam Translation and Validation. Indian J Palliat Care, 25(4), 556-61.
  28. Canon, J., Rex, K., Saiki, A.Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C.G., Koppada, N., Lanman, B.A., Werner, J., Rapaport, A.S., San Miguel, T., Ortiz, R., Osgood, T., Sun, J.R., Zhu, X., McCarter, J.D., Volak, L.P., Houk, B.E., Fakih, M.G., O'Neil, B.H., Price, T.J., Falchook, G.S., Desai, J., Kuo, J., Govindan, R., Hong, D.S., Ouyang, W., Henary, H., Arvedson, T., Cee, V.J., & Lipford, J.R. (2019). The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 575(7781), 217-23.
  29. Ferrell, B., Williams, A.C., Borneman, T., Chung, V., & Smith, T.J. (2019). Clinical Trials Understanding patient perspectives and beliefs about treatment. Clin J Oncol Nurs, 23(6), 592-8.
  30. Yeon, E.K., Sung, J.Y., Do, S.I., Park, B.J., Kim, E.J., & Na, K. (2019). Clinicoradiological Features of Recurrent Meningioma With High Grade Transformation. Anticancer Res, 39(11), 6299-305.
  31. Mohile, S.G., Epstein, R.M., Hurria, A., Heckler, C.E., Canin, B., Culakova, E., Duberstein, P., Gilmore, N., Xu, H., Plumb, S., Wells, M., Lowenstein, L.M., Flannery, M.A., Janelsins, M., Magnuson, A., Loh, K.P., Kleckner, A.S., Mustian, K.M., Hopkins, J.O., Liu, J.J., Geer, J., Gorawara-Bhat, R., Morrow, G.R., & Dale, W. (2019). Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program. JAMA Oncol.
  32. Al-Refaie, W.B., Decker, P.A., Ballman, K.V., Pisters, P.W.T., Posner, M.C., Hunt, K.K., Meyers, B., Weinberg, A.D., Nelson, H., Newman, L., Tan, A., Le-Rademacher, J.G., Hurria, A., & Jatoi, A. (2019). Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol, 26(13), 4213-21.
  33. Carbunaru, S., Nettey, O.S., Gogana, P., Helenowski, I.B., Jovanovic, B., Ruden, M., Hollowell, C.M.P., Sharifi, R., Kittles, R.A., Schaeffer, E., Gann, P., & Murphy, A.B. (2019). A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort. BMC Urol, 19, Article number: 121.
  34. Olson, A., Le, V., Aldahl, J., Yu, E.J., Hooker, E., He, Y., Lee, D.H., Kim, W.K., Cardiff, R.D., Geradts, J., & Sun, Z. (2019). The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. PLoS Genet, 15(10), e1008451.
  35. Henschke, C.I., Yip, R., Ma, T., Aguayo, S.M., Zulueta, J., Yankelevitz, D.F., Henschke, C.I., Yankelevitz, D.F., Yip, R., Xu, D.M., Salvatore, M., Flores, R., Wolf, A., McCauley, D.I., Chen, M., Libby, D.M., Miettinen, O.S., Smith, J.P., Pasmantier, M., Reeves, A.P., Markowitz, S., Miller, A., Deval, J.C., Schmidt, H., Patsios, D., Sone, S., Hanaoka, T., Zulueta, J., Montuenga, L., Lozano, M.D., Aye, R., Bauer, T., Canitano, S., Giunta, S., Cole, E., Klingler, K., Austin, J.H.M., Pearson, G.D.N., Shaham, D., Aylesworth, C., Meyers, P., Andaz, S., Vafai, D., Naidich, D., McGuinness, G., Sheppard, B., Rifkin, M., Thorsen, M.K., Hansen, R., Kopel, S., Mayfield, W., Luedke, D., Klippenstein, D., Litwin, A., Loud, P.A., Kohman, L.J., Scalzetti, E.M., Thurer, R., Khan, A., Shah, R., Liu, X.G., Herzog, G., Yeh, D., Wu, N., Lowry, J., Salvatore, M., Frumiento, C., Mendelson, D.S., Smith, M.V., Korst, R., Taylor, J., Heelan, R.T., Ginsberg, M.S., Straznicka, M., Widmann, M., Cecchi, G., Matalon, T.A.S., Scheinberg, P., Odzer, S.L., Olsen, D., Grannis, F., Rotter, A., Ray, D., Mullen, D., Wiernik, P.H., Cheung, E.H., Lim, M., DeCunzo, L., Glassberg, R., Pass, H., Endress, C., Yoder, M., Shah, P., Welch, L., Kalafer, M., Green, J., Camacho, E., Chin, C., O'Brien, J., Gorden, D., Koch, A., Wiley, J., & I-ELCAP Investigators. (2019). CT screening for lung cancer: comparison of three baseline screening protocols. Eur Radiol, 29(10), 5217-26.
  36. Graham, J., Wells, J.C., Donskov, F., Lee, J.L., Fraccon, A., Pasini, F., Porta, C., Bowman, I.A., Bjarnason, G.A., Ernst, D.S., Rha, S.Y., Beuselinck, B., Hansen, A., North, S.A., Kollmannsberger, C.K., Wood, L.A., Vaishampayan, U.N., Pal, S.K., Choueiri, T.K., & Heng, D.Y.C. (2019). Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol, 2(6), 643-8.
  37. Zhang, Z.Z., Shao, M.L., Hepler, C., Zi, Z.Z., Zhao, S.G., An, Y.A., Zhu, Y., Ghaben, A.L., Wang, M.Y., Li, N., Onodera, T., Joffin, N., Crewe, C., Zhu, Q.Z., Vishvanath, L., Kumar, A., Xing, C., Wang, Q.A., Gautron, L., Deng, Y.F., Gordillo, R., Kruglikov, I., Kusminski, C.M., Gupta, R.K., & Scherer, P.E. (2019). Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J Clin Invest, 129(12), 5327-42.
  38. Zhu, Y., Smith, D.J., Zhou, Y., Li, Y.R., Yu, J., Lee, D., Wang, Y.C., Di Biase, S., Wang, X., Hardoy, C., Ku, J., Tsao, T., Lin, L.J., Pham, A.T., Moon, H., McLaughlin, J., Cheng, D., Hollis, R.P., Campo-Fernandez, B., Urbinati, F., Wei, L., Pang, L., Rezek, V., Berent-Maoz, B., Macabali, M.H., Gjertson, D., Wang, X., Galic, Z., Kitchen, S.G., An, D.S., Hu-Lieskovan, S., Kaplan-Lefko, P.J., De Oliveira, S.N., Seet, C.S., Larson, S.M., Forman, S.J., Heath, J.R., Zack, J.A., Crooks, G.M., Radu, C.G., Ribas, A., Kohn, D.B., Witte, O.N., & Yang, L. (2019). Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer. Cell Stem Cell, 25(4), 542-57 e9.
  39. Bauer, B.M., Williams, N.L., & Zuckerman, L.M. (2019). Development of multifocal extra-abdominal desmoid fibromatosis after surgical resection. Clin Case Rep, 7(12), 2515-9.
  40. Chu, F.F., Esworthy, R.S., Shen, B., Gao, Q., & Doroshow, J.H. (2019). Dexamethasone and Tofacitinib suppress NADPH oxidase expression and alleviate very-early-onset ileocolitis in mice deficient in GSH peroxidase 1 and 2. Life Sci, 239, 116884.
  41. Petrick, J.L., Li, N., Anderson, L.A., Bernstein, L., Corley, D.A., El Serag, H.B., Hardikar, S., Liao, L.M., Liu, G., Murray, L.J., Rubenstein, J.H., Schneider, J.L., Shaheen, N.J., Thrift, A.P., van den Brandt, P.A., Vaughan, T.L., Whiteman, D.C., Wu, A.H., Zhao, W.K., Gammon, M.D., & Cook, M.B. (2019). Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer, 125(23), 4210-23.
  42. Riba, M.B., Donovan, K.A., Andersen, B., Braun, I., Breitbart, W.S., Brewer, B.W., Buchmann, L.O., Clark, M.M., Collins, M., Corbett, C., Fleishman, S., Garcia, S., Greenberg, D.B., Handzo, R.G.F., Hoofring, L., Huang, C.H., Lally, R., Martin, S., McGuffey, L., Mitchell, W., Morrison, L.J., Pailler, M., Palesh, O., Parnes, F., Pazar, J.P., Ralston, L., Salman, J., Shannon-Dudley, M.M., Valentine, A.D., McMillian, N.R., & Darlow, S.D. (2019). Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(10), 1229-49.
  43. Dean, L.T., Ransome, Y., Frasso-Jaramillo, L., Moss, S.L., Zhang, Y., Ashing, K., Denis, G.V., Frick, K.D., Visvanathan, K., & Schmitz, K.H. (2019). Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv, 13(5), 804-14.
  44. Zettlitz, K.A., Waldmann, C.M., Tsai, W.T.K., Tavare, R., Collins, J., Murphy, J.M., & Wu, A.M. (2019). A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for F-18-Immuno-PET and Fluorescence Imaging. J Nucl Med, 60(10), 1467-73.
  45. Nguyen, D.Q., Hoang, D.H., Nguyen, T.T.V., Ho, H.D., Huynh, V., Shin, J.H., Ly, Q.T., Nguyen, D.D.T., Ghoda, L., Marcucci, G., & Nguyen, L.X.T. (2019). Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis. J Cell Physiol, 234(10), 17612-21.
  46. Fisher, B.T., Zaoutis, T., Dvorak, C.C., Nieder, M., Zerr, D., Wingard, J.R., Callahan, C., Villaluna, D., Chen, L., Dang, H., Esbenshade, A.J., Alexander, S., Wiley, J.M., & Sung, L. (2019). Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial. JAMA, 322(17), 1673-81.
  47. Mascarenhas, K., Teh, J.B., Peng, K., Kim, H., Sy, A., Forman, S.J., Wong, F.L., Nakamura, R., Dadwal, S.S., & Armenian, S.H. (2019). Efficacy of low-dose zoster prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant.
  48. Gong, J., Robertson, M.D., Kim, E., Fakih, M., Schrock, A.B., Tam, K.W., Burugapalli, B., Monjazeb, A.M., Hendifar, A.E., Hitchins, M., Klempner, S.J., & Cho, M. (2019). Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer, 18(4), 307-9.
  49. Nath, A., & Huang, R.S. (2019). Emerging role of long non-coding RNAs in cancer precision medicine. Molecular & Cellular Oncology, 7(1).
  50. Gilmore, N.J., Canin, B., Whitehead, M., Sedenquist, M., Griggs, L., Finch, L., Grossman, V., Targia, V., Wells, M., Kamen, C., Flannery, M., Magnuson, A., Plumb, S., Obrecht, S., Lowenstein, L.M., Lopez, G., Anderson, J., Berenberg, J., Vogel, V., Bearden, J., Dale, W., & Mohile, S.G. (2019). Engaging older patients with cancer and their caregivers as partners in cancer research. Cancer, 125(23), 4124-33.
  51. Adams, C.D., & Neuhausen, S.L. (2019). Evaluating causal associations between chronotype and fatty acids and between fatty acids and type 2 diabetes: A Mendelian randomization study. Nutr Metab Cardiovasc Dis, 29(11), 1176-84.
  52. Solomon, I., Rybak, C., Van Tongeren, L., Kuzmich, L., Blazer, K., Nehoray, B., Niell-Swiller, M., Bray, S., Bray, T.H., Hurley, K., Weitzel, J.N., & Slavin, T.P. (2019). Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. J Cancer Educ, 34(6), 1204-12.
  53. Chang, Y.J., Li, Y.S., Wu, C.C., Wang, K.C., Huang, Z.C.E., Chen, Z., & Chien, S. (2019). Extracellular MicroRNA-92a Mediates Endothelial Cell-Macrophage Communication. Arterioscler Thromb Vasc Biol, 39(12), 2492-504.
  54. Copeland, B.T., Du, J., Pal, S.K., & Jones, J.O. (2019). Factors that influence the androgen receptor cistrome in benign and malignant prostate cells. Mol Oncol, 13(12), 2616-32.
  55. Ferrell, B.R. (2019). Family Caregiving and Cancer Pain Management. Anesth Analg, 129(5), 1408-13.
  56. Figlioli, G., Bogliolo, M., Catucci, I., Caleca, L., Lasheras, S.V., Pujol, R., Kiiski, J.I., Muranen, T.A., Barnes, D.R., Dennis, J., Michailidou, K., Bolla, M.K., Leslie, G., Aalfs, C.M., Investigators, A., Adank, M.A., Adlard, J., Agata, S., Cadoo, K., Agnarsson, B.A., Ahearn, T., Aittomaki, K., Ambrosone, C.B., Andrews, L., Anton-Culver, H., Antonenkova, N.N., Arndt, V., Arnold, N., Aronson, K.J., Arun, B.K., Asseryanis, E., Auber, B., Auvinen, P., Azzollini, J., Balmana, J., Barkardottir, R.B., Barrowdale, D., Barwell, J., Beane Freeman, L.E., Beauparlant, C.J., Beckmann, M.W., Behrens, S., Benitez, J., Berger, R., Bermisheva, M., Blanco, A.M., Blomqvist, C., Bogdanova, N.V., Bojesen, A., Bojesen, S.E., Bonanni, B., Borg, A., Brady, A.F., Brauch, H., Brenner, H., Bruning, T., Burwinkel, B., Buys, S.S., Caldes, T., Caliebe, A., Caligo, M.A., Campa, D., Campbell, I.G., Canzian, F., Castelao, J.E., Chang-Claude, J., Chanock, S.J., Claes, K.B.M., Clarke, C.L., Collavoli, A., Conner, T.A., Cox, D.G., Cybulski, C., Czene, K., Daly, M.B., de la Hoya, M., Devilee, P., Diez, O., Ding, Y.C., Dite, G.S., Ditsch, N., Domchek, S.M., Dorfling, C.M., Dos-Santos-Silva, I., Durda, K., Dwek, M., Eccles, D.M., Ekici, A.B., Eliassen, A.H., Ellberg, C., Eriksson, M., Evans, D.G., Fasching, P.A., Figueroa, J., Flyger, H., Foulkes, W.D., Friebel, T.M., Friedman, E., Gabrielson, M., Gaddam, P., Gago-Dominguez, M., Gao, C., Gapstur, S.M., Garber, J., Garcia-Closas, M., Garcia-Saenz, J.A., Gaudet, M.M., Gayther, S.A., Collaborators, G.S., Giles, G.G., Glendon, G., Godwin, A.K., Goldberg, M.S., Goldgar, D.E., Guenel, P., Gutierrez-Barrera, A.M., Haeberle, L., Haiman, C.A., Hakansson, N., Hall, P., Hamann, U., Harrington, P.A., Hein, A., Heyworth, J., Hillemanns, P., Hollestelle, A., Hopper, J.L., Hosgood, H.D., 3rd, Howell, A., Hu, C., Hulick, P.J., Hunter, D.J., Imyanitov, E.N., KconFab, Isaacs, C., Jakimovska, M., Jakubowska, A., James, P., Janavicius, R., Janni, W., John, E.M., Jones, M.E., Jung, A., Kaaks, R., Karlan, B.Y., Khusnutdinova, E., Kitahara, C.M., Konstantopoulou, I., Koutros, S., Kraft, P., Lambrechts, D., Lazaro, C., Le Marchand, L., Lester, J., Lesueur, F., Lilyquist, J., Loud, J.T., Lu, K.H., Luben, R.N., Lubinski, J., Mannermaa, A., Manoochehri, M., Manoukian, S., Margolin, S., Martens, J.W.M., Maurer, T., Mavroudis, D., Mebirouk, N., Meindl, A., Menon, U., Miller, A., Montagna, M., Nathanson, K.L., Neuhausen, S.L., Newman, W.G., Nguyen-Dumont, T., Nielsen, F.C., Nielsen, S., Nikitina-Zake, L., Offit, K., Olah, E., Olopade, O.I., Olshan, A.F., Olson, J.E., Olsson, H., Osorio, A., Ottini, L., Peissel, B., Peixoto, A., Peto, J., Plaseska-Karanfilska, D., Pocza, T., Presneau, N., Pujana, M.A., Punie, K., Rack, B., Rantala, J., Rashid, M.U., Rau-Murthy, R., Rennert, G., Lejbkowicz, F., Rhenius, V., Romero, A., Rookus, M.A., Ross, E.A., Rossing, M., Rudaitis, V., Ruebner, M., Saloustros, E., Sanden, K., Santamarina, M., Scheuner, M.T., Schmutzler, R.K., Schneider, M., Scott, C., Senter, L., Shah, M., Sharma, P., Shu, X.O., Simard, J., Singer, C.F., Sohn, C., Soucy, P., Southey, M.C., Spinelli, J.J., Steele, L., Stoppa-Lyonnet, D., Tapper, W.J., Teixeira, M.R., Terry, M.B., Thomassen, M., Thompson, J., Thull, D.L., Tischkowitz, M., Tollenaar, R., Torres, D., Troester, M.A., Truong, T., Tung, N., Untch, M., Vachon, C.M., van Rensburg, E.J., van Veen, E.M., Vega, A., Viel, A., Wappenschmidt, B., Weitzel, J.N., Wendt, C., Wieme, G., Wolk, A., Yang, X.R., Zheng, W., Ziogas, A., Zorn, K.K., Dunning, A.M., Lush, M., Wang, Q., McGuffog, L., Parsons, M.T., Pharoah, P.D.P., Fostira, F., Toland, A.E., Andrulis, I.L., Ramus, S.J., Swerdlow, A.J., Greene, M.H., Chung, W.K., Milne, R.L., Chenevix-Trench, G., Dork, T., Schmidt, M.K., Easton, D.F., Radice, P., Hahnen, E., Antoniou, A.C., Couch, F.J., Nevanlinna, H., Surralles, J., & Peterlongo, P. (2019). The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer, 5, 38.
  57. Wang, L., Gong, Y., Saci, A., Szabo, P.M., Martini, A., Necchi, A., Siefker-Radtke, A., Pal, S., Plimack, E.R., Sfakianos, J.P., Bhardwaj, N., Horowitz, A., Farkas, A.M., Mulholland, D., Fischer, B.S., Oh, W.K., Sharma, P., Zhu, J., & Galsky, M.D. (2019). Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer. Eur Urol, 76(5), 599-603.
  58. Dudani, S., Graham, J., Wells, J.C., Bakouny, Z., Pal, S.K., Dizman, N., Donskov, F., Porta, C., de Velasco, G., Hansen, A., Iafolla, M., Beuselinck, B., Vaishampayan, U.N., Wood, L.A., Liow, E., Yan, F., Yuasa, T., Bjarnason, G.A., Choueiri, T.K., & Heng, D.Y.C. (2019). First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium. Eur Urol, 76(6), 861-7.
  59. Loo, V., Salgia, M., Bergerot, P., Philip, E.J., & Pal, S.K. (2019). First-Line Systemic Therapy for Metastatic Clear-Cell Renal Cell Carcinoma: Critical Appraisal of Emerging Options. Target Oncol, 14(6), 639-45.
  60. Hahn, A.W., Klaassen, Z., Agarwal, N., Haaland, B., Esther, J., Ye, X.Y., Wang, X., Pal, S.K., & Wallis, C.J.D. (2019). First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis. Eur Urol Oncol, 2(6), 708-15.
  61. Kamdar, M., Li, H., Chen, R.W., Rimsza, L.M., Leblanc, M.L., Fenske, T.S., Shea, T.C., Barr, P.M., Phillips, T.J., Leonard, J.P., Kahl, B.S., Friedberg, J.W., & Smith, S.M. (2019). Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma. Blood Adv, 3(20), 3132-5.
  62. Ali, S., Zhang, Y., Zhou, M., Li, H., Jin, W., Zheng, L., Yu, X., Stark, J.M., Weitzel, J.N., & Shen, B. (2019). Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis. Oncogene.
  63. Sette, P., Amankulor, N., Li, A., Marzulli, M., Leronni, D., Zhang, M., Goins, W.F., Kaur, B., Bolyard, C., Cripe, T.P., Yu, J., Chiocca, E.A., Glorioso, J.C., & Grandi, P. (2019). GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival. Mol Ther Oncolytics, 15, 214-22.
  64. Din, L., Sheikh, M., Kosaraju, N., Smedby, K.E., Bernatsky, S., Berndt, S.I., Skibola, C.F., Nieters, A., Wang, S., McKay, J.D., Cocco, P., Maynadie, M., Foretova, L., Staines, A., Mack, T.M., de Sanjose, S., Vyse, T.J., Padyukov, L., Monnereau, A., Arslan, A.A., Moore, A., Brooks-Wilson, A.R., Novak, A.J., Glimelius, B., Birmann, B.M., Link, B.K., Stewart, C., Vajdic, C.M., Haioun, C., Magnani, C., Conti, D.V., Cox, D.G., Casabonne, D., Albanes, D., Kane, E., Roman, E., Muzi, G., Salles, G., Giles, G.G., Adami, H.O., Ghesquieres, H., De Vivo, I., Clavel, J., Cerhan, J.R., Spinelli, J.J., Hofmann, J., Vijai, J., Curtin, K., Costenbader, K.H., Onel, K., Offit, K., Teras, L.R., Morton, L., Conde, L., Miligi, L., Melbye, M., Ennas, M.G., Liebow, M., Purdue, M.P., Glenn, M., Southey, M.C., Din, M., Rothman, N., Camp, N.J., Wong Doo, N., Becker, N., Pradhan, N., Bracci, P.M., Boffetta, P., Vineis, P., Brennan, P., Kraft, P., Lan, Q., Severson, R.K., Vermeulen, R.C.H., Milne, R.L., Kaaks, R., Travis, R.C., Weinstein, S.J., Chanock, S.J., Ansell, S.M., Slager, S.L., Zheng, T., Zhang, Y., Benavente, Y., Taub, Z., Madireddy, L., Gourraud, P.A., Oksenberg, J.R., Cozen, W., Hjalgrim, H., & Khankhanian, P. (2019). Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genet Epidemiol, 43(7), 844-63.
  65. McCorrison, J., Girke, T., Goetz, L.H., Miller, R.A., & Schork, N.J. (2019). Genetic Support for Longevity-Enhancing Drug Targets: Issues, Preliminary Data, and Future Directions. J Gerontol A Biol Sci Med Sci, 74(Supplement_1), S61-S71.
  66. Abu-Rustum, N.R., Yashar, C.M., Bean, S., Bradley, K., Campos, S.M., Chon, H.S., Chu, C., Cohn, D., Crispens, M.A., Damast, S., Dorigo, O., Eifel, P.J., Fisher, C.M., Frederick, P., Gaffney, D.K., Han, E., Huh, W.K., Lurain, J.R., Mariani, A., Mutch, D., Nagel, C., Nekhlyudov, L., Fader, A.N., Remmenga, S.W., Reynolds, R.K., Sisodia, R., Tillmanns, T., Ueda, S., Wyse, E., McMillian, N.R., & Scavone, J. (2019). Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 17(11), 1374-91.
  67. Tremblay, J.R., Lopez, K., & Ku, H.T. (2019). A GLIS3-CD133-WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids. J Biol Chem, 294(45), 16634-49.
  68. Pahwa, M., Beane Freeman, L.E., Spinelli, J.J., Blair, A., McLaughlin, J.R., Zahm, S.H., Cantor, K.P., Weisenburger, D.D., Punam Pahwa, P.P., Dosman, J.A., Demers, P.A., & Harris, S.A. (2019). Glyphosate use and associations with non-Hodgkin lymphoma major histological sub-types: findings from the North American Pooled Project. Scand J Work Environ Health, 45(6), 600-9.
  69. Song, J.Y., & Querfeld, C. (2019). The great masquerader mimicking plasma cell myeloma. Blood, 134(17), 1481.
  70. Gupta, R., Othman, T., Chen, C., Sandhu, J., Ouyang, C., & Fakih, M. (2019). Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer. Oncologist, 24.
  71. Blakely, A.M., Chanson, D., Wong, F.L., Eng, O.S., Sentovich, S.M., Melstrom, K.A., Lai, L.L., Fong, Y., & Sun, V. (2019). Health-related quality of life and oncologic outcomes after surgery in older adults with colorectal cancer. Support Care Cancer.
  72. Visweshwar, N., Jaglal, M., Sokol, L., & Djulbegovic, B. (2019). Hematological Malignancies and Arterial Thromboembolism. Indian J Hematol Blood Transfus, 35(4), 611-24.
  73. King, E., & Nehoray, B.M. (2019). Hereditary Pancreatic Cancer Syndromes Providing care to at-risk families. Clin J Oncol Nurs, 23(6), 579-82.
  74. Stewart, C.L., Dumitra, S., Nota, C., Ituarte, P.H.G., Melstrom, L.G., Woo, Y., Singh, G., Fong, Y., Nathan, H., & Warner, S.G. (2019). Hospital factors strongly influence robotic use in general surgery. Surgery, 166(5), 867-72.
  75. Xu, X., Ritz, B., Coleman, A., Liew, Z., Deapen, D., Lee, E., Bernstein, L., Pinder, R., Marshall, S., & Heck, J.E. (2019). Hypertension, antihypertensive medications use and risk of age-related macular degeneration in California Teachers Cohort. J Hum Hypertens.
  76. Waller, E.K., Miklos, D., Cutler, C., Arora, M., Jagasia, M.H., Pusic, I., Flowers, M.E.D., Logan, A.C., Nakamura, R., Chang, S., Clow, F., Lal, I.D., Styles, L., & Jaglowski, S. (2019). Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study. Biol Blood Marrow Transplant, 25(10), 2002-7.
  77. Mutsvunguma, L.Z., Rodriguez, E., Escalante, G.M., Muniraju, M., Williams, J.C., Warden, C., Qin, H., Wang, J., Wu, X., Barasa, A., Mulama, D.H., Mwangi, W., & Ogembo, J.G. (2019). Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes. Virology, 536, 1-15.
  78. Copeland, B., Shallal, H., Shen, C.T., Pienta, K.J., Foss, C.A., & Pomper, M.G. (2019). Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer. Mol Imag Biol, 21(6), 1054-63.
  79. Fakih, M., Ouyang, C., Wang, C., Tu, T.Y., Gozo, M.C., Cho, M., Sy, M., Longmate, J.A., & Lee, P.P. (2019). Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. J Clin Invest, 129(10), 4464-76.
  80. Kidambi, T.D., Chu, P., Lee, J.K., & Lin, J.L. (2019). Immunotherapy-Associated Pseudomembranous Colitis. Am J Gastroenterol, 114(11), 1708.
  81. Conley, C.C., Kasting, M.L., Augusto, B.M., Garcia, J.D., Cragun, D., Gonzalez, B.D., Kim, J., Ashing, K.T., Knott, C.L., Hughes-Halbert, C., Pal, T., & Vadaparampil, S.T. (2019). Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study. Ann Surg Oncol.
  82. Li, R., Shinde, A., Fakih, M., Sentovich, S., Melstrom, K., Nelson, R., Glaser, S., Chen, Y.J., Goodman, K., & Amini, A. (2019). Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma. J Natl Compr Canc Netw, 17(10), 1203-10.
  83. Zecha, J., Raber-Durlacher, J.E., Laheij, A., Westermann, A.M., Epstein, J.B., de Lange, J., & Smeele, L.E. (2019). The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy. Support Care Cancer, 27(10), 3667-79.
  84. Scott, T., Urak, R., Soemardy, C., & Morris, K.V. (2019). Improved Cas9 activity by specific modifications of the tracrRNA. Sci Rep, 9, Article number: 16104.
  85. Oxnard, G.R., West, H.J., & King, J.C. (2019). Improving Molecular Oncology by Making Results Available to Patients. JAMA Oncol, 5(12), 1689-90.
  86. Freeman, M., Betts, K.A., Jiang, S., Du, E.X., Gupte-Singh, K., Lu, Y.C., Rao, S., & Shoushtari, A.N. (2019). Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data. Adv Ther, 36(10), 2783-96.
  87. Ornstein, M.C., Pal, S.K., Wood, L.S., Tomer, J.M., Hobbs, B.P., Jia, X.S., Allman, K.D., Martin, A., Olencki, T., Davis, N.B., Gilligan, T.D., Mortazavi, A., Rathmell, W.K., Garcia, J.A., & Rini, B.I. (2019). Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study. Lancet Oncol, 20(10), 1386-94.
  88. Rodriguez-Hernandez, G., Opitz, F.V., Delgado, P., Walter, C., Alvarez-Prado, A.F., Gonzalez-Herrero, I., Auer, F., Fischer, U., Janssen, S., Bartenhagen, C., Raboso-Gallego, J., Casado-Garcia, A., Orfao, A., Blanco, O., Alonso-Lopez, D., Rivas, J.L., Tena-Davila, S.G., Muschen, M., Dugas, M., Criado, F.J.G., Cenador, M.B.G., Vicente-Duenas, C., Hauer, J., Ramiro, A.R., Sanchez-Garcia, I., & Borkhardt, A. (2019). Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nat Commun, 10, Article number: 5563.
  89. Nakamura, R., Gendzekhadze, K., Palmer, J., Tsai, N.C., Mokhtari, S., Forman, S.J., Zaia, J.A., Senitzer, D., Marcucci, G., & Stein, A. (2019). Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation. Leuk Res, 87, 106230.
  90. Barzi, A., Lara, P.N., Jr., Tsao-Wei, D., Yang, D., Gill, I.S., Daneshmand, S., Klein, E.A., Pinski, J.K., Penson, D.F., Quinn, D.I., & Sadeghi, S. (2019). Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy. Cancer, 125(21), 3853-63.
  91. Khiatah, B., Qi, M., Du, W., K, T.C., van Megen, K.M., Perez, R.G., Isenberg, J.S., Kandeel, F., Roep, B.O., Ku, H.T., & Al-Abdullah, I.H. (2019). Intra-pancreatic tissue-derived mesenchymal stromal cells: a promising therapeutic potential with anti-inflammatory and pro-angiogenic profiles. Stem Cell Res Ther, 10, Article number: 322.
  92. Yamamura, K., Izumi, D., Kandimalla, R., Sonohara, F., Baba, Y., Yoshida, N., Kodera, Y., Baba, H., & Goel, A. (2019). Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res, 25(20), 6170-9.
  93. Aldoss, I., Dadwal, S., Zhang, J.Y., Tegtmeier, B., Mei, M., Arslan, S., Al Malki, M.M., Salhotra, A., Ali, H., Aribi, A., Sandhu, K., Khaled, S., Snyder, D., Nakamura, R., Stein, A.S., Forman, S.J., Marcucci, G., & Pullarkat, V. (2019). Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents. Blood Advances, 3(23), 4043-9.
  94. Melstrom, L.G., Eng, O.S., Raoof, M., Singh, G., Fong, Y., Latorre, K., Choi, G.H., Salem, R., Bentrem, D.J., Lewandowski, R., Makris, E., Poultsides, G., Dhar, V.K., Chadalavada, S., Shah, S.A., Johnson, A.C., Sekhar, A., Kies, D., Maithel, S.K., Rocha, F., Alseidi, A., Hagendoorn, J., Rinkes, I., Fisher, A.V., Ronnekleiv-Kelly, S., Weber, S.M., Winslow, E.R., & Abbott, D.E. (2019). Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience. HPB (Oxford), 21(11), 1520-6.
  95. Dumitrescu, T.P., McCune, J., & Schmith, V. (2019). Is Placebo Response Responsible for Many Phase III Failures? Clin Pharmacol Ther, 106(6), 1151-4.
  96. Gonzalez, N., Salgado, M., Medrano, L., Mullen, Y., & Komatsu, H. (2019). Isolated pancreatic islet yield and quality is inversely related to organ donor age in rats. Exp Gerontol, 128, 110739.
  97. Liu, C., Liu, H., Lu, C., Deng, J., Yan, Y., Chen, H., Wang, Y., Liang, C.L., Wei, J., Han, L., & Dai, Z. (2019). Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clin Exp Immunol, 198(3), 403-15.
  98. Motzer, R.J., Jonasch, E., Michaelson, M.D., Nandagopal, L., Gore, J.L., George, S., Alva, A., Haas, N., Harrison, M.R., Plimack, E.R., Sosman, J., Agarwal, N., Bhayani, S., Choueiri, T.K., Costello, B.A., Derweesh, I.H., Gallagher, T.H., Hancock, S.L., Kyriakopoulos, C., LaGrange, C., Lam, E.T., Lau, C., Lewis, B., Manley, B., McCreery, B., McDonald, A., Mortazavi, A., Pierorazio, P.M., Ponsky, L., Redman, B.G., Somer, B., Wile, G., Dwyer, M.A., Hammond, L.J., & Zuccarino-Catania, G. (2019). Kidney Cancer, Version 2.2020 Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 17(11), 1279-85.
  99. Wu, J., Chen, Y., Hageman, L., Francisco, L., Ness, E.C., Parman, M., Kung, M., Watson, J.A., Weisdorf, D.J., Snyder, D.S., McGlave, P.B., Forman, S.J., Arora, M., Armenian, S.H., Bhatia, R., & Bhatia, S. (2019). Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report. Cancer, 125(22), 4033-42.
  100. Raoof, M., Haye, S., Ituarte, P.H.G., & Fong, Y. (2019). Liver Resection Improves Survival in Colorectal Cancer Patients. Ann Surg, 270(4), 692-700.
  101. Bilinovich, S.M., Lewis, K., Grepo, N., & Campbell, D.B. (2019). The Long Noncoding RNA RPS10P2-AS1 Is Implicated in Autism Spectrum Disorder Risk and Modulates Gene Expression in Human Neuronal Progenitor Cells. Front Genet, 10(OCT), Article number: 970.
  102. Beard, R.E., Khan, S., Troisi, R.I., Montalti, R., Vanlander, A., Fong, Y., Kingham, T.P., Boerner, T., Berber, E., Kahramangil, B., Buell, J.F., Martinie, J.B., Vrochides, D., Shen, C., Molinari, M., Geller, D.A., & Tsung, A. (2019). Long-Term and Oncologic Outcomes of Robotic Versus Laparoscopic Liver Resection for Metastatic Colorectal Cancer: A Multicenter, Propensity Score Matching Analysis. World J Surg.
  103. Grannis, F.W., Jr. (2019). Lung Cancer Incidence and Mortality with Extended Follow-up during Screening. J Thorac Oncol, 14(10), 1692-4.
  104. Blakely, A.M., Raoof, M., Ituarte, P.H.G., Fong, Y., Singh, G., & Lee, B. (2019). Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors. Ann Surg Oncol, 26(12), 4008-15.
  105. Zou, D., Dong, L., Li, C., Yin, Z., Rao, S., & Zhou, Q. (2019). The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int, 19, Article number: 321.
  106. Muk, S., Ghosh, S., Achuthan, S., Chen, X., Yao, X., Sandhu, M., Griffor, M.C., Fennell, K.F., Che, Y., Shanmugasundaram, V., Qiu, X., Tate, C.G., & Vaidehi, N. (2019). Machine Learning for Prioritization of Thermostabilizing Mutations for G-Protein Coupled Receptors. Biophys J, 117(11), 2228-39.
  107. Srinagesh, H.K., Ozbek, U., Kapoor, U., Ayuk, F., Aziz, M., Ben-David, K., Choe, H.K., DeFilipp, Z., Etra, A., Grupp, S.A., Hartwell, M.J., Hexner, E.O., Hogan, W.J., Karol, A.B., Kasikis, S., Kitko, C.L., Kowalyk, S., Lin, J.Y., Major-Monfried, H., Mielke, S., Merli, P., Morales, G., Ordemann, R., Pulsipher, M.A., Qayed, M., Reddy, P., Reshef, R., Rosler, W., Sandhu, K.S., Schechter, T., Shah, J., Sigel, K., Weber, D., Wolfl, M., Wudhikarn, K., Young, R., Levine, J.E., & Ferrara, J.L.M. (2019). The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Advances, 3(23), 4034-42.
  108. Wu, W., Yan, Z., Nguyen, T.C., Bouman Chen, Z., Chien, S., & Zhong, S. (2019). Mapping RNA-chromatin interactions by sequencing with iMARGI. Nat Protoc, 14(11), 3243-72.
  109. Dixit, H.G., Starr, R., Dundon, M.L., Pairs, P.I., Yang, X., Zhang, Y., Nampe, D., Ballas, C.B., Tsutsui, H., Forman, S.J., Brown, C.E., & Rao, M.P. (2019). Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery. Nano Lett.
  110. Dong, W., Wu, X., Ma, S., Wang, Y., Nalin, A.P., Zhu, Z., Zhang, J., Benson, D.M., He, K., Caligiuri, M.A., & Yu, J. (2019). The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector. Cancer Discov, 9(10), 1422-37.
  111. Rosenzweig, M.Q., Bailey, D.E., Bush, N.J., Coombs, L.A., Lehto, R.H., Loerzel, V., Sun, V., Mooney, K., & Cooley, M.E. (2019). Mentorship for Nurse Scientists: Strategies for Growth From the Oncology Nursing Society Research Mentorship Task Force. Oncol Nurs Forum, 46(6), 769-74.
  112. Iglesias, G.M., Canet, Z.E., Cantaro, H., Miquel, M.C., Melo, J.E., Miller, M.M., Berres, M.E., & Fulton, J.E. (2019). Mhc-B haplotypes in "Campero-Inta" chicken synthetic line. Poult Sci, 98(11), 5281-6.
  113. Engevik, M.A., Morra, C.N., Roth, D., Engevik, K., Spinler, J.K., Devaraj, S., Crawford, S.E., Estes, M.K., Kalkum, M., & Versalovic, J. (2019). Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors. Front Microbiol, 10, Article number: 2305.
  114. Khalife, J., Ghose, J., Martella, M., Viola, D., Rocci, A., Troadec, E., Terrazas, C., Satoskar, A.R., Gunes, E.G., Dona, A., Sanchez, J.F., Bergsagel, P.L., Chesi, M., Pozhitkov, A., Rosen, S., Marcucci, G., Keats, J.J., Hofmeister, C.C., Krishnan, A., Caserta, E., & Pichiorri, F. (2019). MiR-16 regulates crosstalk in NF-kappaB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophages. JCI Insight, 4(21), e129348.
  115. Gokbuget, N., Kantarjian, H.M., Bruggemann, M., Stein, A.S., Bargou, R.C., Dombret, H., Fielding, A.K., Heffner, L., Rigal-Huguet, F., Litzow, M., O'Brien, S., Zugmaier, G., Gao, S., Nagorsen, D., Forman, S.J., & Topp, M.S. (2019). Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Blood Adv, 3(20), 3033-7.
  116. Mirzapoiazova, T., Li, H., Nathan, A., Srivstava, S., Nasser, M.W., Lennon, F., Armstrong, B., Mambetsariev, I., Chu, P.G., Achuthan, S., Batra, S.K., Kulkarni, P., & Salgia, R. (2019). Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells. J Clin Med, 8(10), Article number: 1723.
  117. Horn, L., Whisenant, J.G., Wakelee, H., Reckamp, K.L., Qiao, H., Leal, T.A., Du, L., Hernandez, J., Huang, V., Blumenschein, G.R., Waqar, S.N., Patel, S.P., Nieva, J., Oxnard, G.R., Sanborn, R.E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L.P., Li, M., & Lovly, C.M. (2019). Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer. J Thorac Oncol, 14(11), 1901-11.
  118. Aldoss, I., & Marcucci, G. (2019). More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabine. Chin Clin Oncol, 8(Suppl 1), S25.
  119. Zuro, D., Vagge, S., Broggi, S., Agostinelli, S., Takahashi, Y., Brooks, J., Leszcynska, P., Liu, A., Zucchetti, C., Saldi, S., Han, C., Cattaneo, M., Giebel, S., Mahe, M.A., Sanchez, J.F., Alaei, P., Anna, C., Dusenbery, K., Pierini, A., Storme, G., Aristei, C., Wong, J.Y.C., & Hui, S. (2019). Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation. Radiother Oncol, 141, 275-82.
  120. Kumar, S.K., Callender, N.S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., Castillo, J.J., Chandler, J.C., Cornell, R.F., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Holmberg, L., Htut, M., Huff, C.A., Kang, Y., Landgren, O., Malek, E., Martin, T., Omel, J., Raje, N., Sborov, D., Singhal, S., Stockerl-Goldstein, K., Tan, C., Weber, D., Johnson-Chilla, A., Keller, J., & Kumar, R. (2019). Multiple Myeloma, Version 1.2020 Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 17(10), 1155-65.
  121. Afkhami, M., Schmolze, D., Yost, S.E., Frankel, P.H., Dagis, A., Amanam, I.U., Telatar, M., Nguyen, K., Yu, K.W., Luu, T., Pillai, R., Aoun, P.A., Mortimer, J., & Yuan, Y. (2019). Mutation and immune profiling of metaplastic breast cancer: Correlation with survival. PLoS One, 14(11), e0224726.
  122. Solomon, S.R., St Martin, A., Shah, N.N., Fatobene, G., Al Malki, M.M., Ballen, K.K., Bashey, A., Bejanyan, N., Bolanos Meade, J., Brunstein, C.G., DeFilipp, Z., Champlin, R.E., Fuchs, E.J., Hamadani, M., Hematti, P., Kanakry, C.G., McGuirk, J.P., McNiece, I.K., Ciurea, S.O., Pasquini, M.C., Rocha, V., Romee, R., Patel, S.S., Vasu, S., Waller, E.K., Wingard, J.R., Zhang, M.J., & Eapen, M. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood Adv, 3(19), 2836-44.
  123. Motzer, R.J., Jonasch, E., Michaelson, M.D., Nandagopal, L., Gore, J.L., George, S., Alva, A., Haas, N., Harrison, M.R., Plimack, E.R., Sosman, J., Agarwal, N., Bhayani, S., Choueiri, T.K., Costello, B.A., Derweesh, I.H., Gallagher, T.H., Hancock, S.L., Kyriakopoulos, C., LaGrange, C., Lam, E.T., Lau, C., Lewis, B., Manley, B., McCreery, B., McDonald, A., Mortazavi, A., Pierorazio, P.M., Ponsky, L., Redman, B.G., Somer, B., Wile, G., Dwyer, M.A., Cgc, Hammond, L.J., & Zuccarino-Catania, G. (2019). NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw, 17(11), 1278-85.
  124. Kumar, S.K., Callander, N.S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., Castillo, J.J., Chandler, J.C., Cornell, R.F., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Holmberg, L., Htut, M., Huff, C.A., Kang, Y., Landgren, O., Malek, E., Martin, T., Omel, J., Raje, N., Sborov, D., Singhal, S., Stockerl-Goldstein, K., Tan, C., Weber, D., Johnson-Chilla, A., Keller, J., & Kumar, R. (2019). NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw, 17(10), 1154-65.
  125. Jin, W., Mulas, F., Gaertner, B., Sui, Y., Wang, J., Matta, I., Zeng, C., Vinckier, N., Wang, A., Nguyen-Ngoc, K.V., Chiou, J., Kaestner, K.H., Frazer, K.A., Carrano, A.C., Shih, H.P., & Sander, M. (2019). A Network of microRNAs Acts to Promote Cell Cycle Exit and Differentiation of Human Pancreatic Endocrine Cells. iScience, 21, 681-94.
  126. De Andrade, J.P., Blakely, A.M., Nguyen, A.H., Ituarte, P.H.G., Warner, S.G., Melstrom, L.G., Lee, B., & Singh, G. (2019). Neuroendocrine Tumors of Meckel's Diverticula: Rare but Fare Well. Am Surg, 85(10), 1125-8. (No DOI provided; our access is through ProQuest:
  127. Dong, J., Gharahkhani, P., Chow, W.H., Gammon, M.D., Liu, G., Caldas, C., Wu, A.H., Ye, W., Onstad, L., Anderson, L.A., Bernstein, L., Pharoah, P.D., Risch, H.A., Corley, D.A., Fitzgerald, R.C., Stomach and Esophageal Cancer Study Consortium, Iyer, P.G., Reid, B.J., Lagergren, J., Shaheen, N.J., Vaughan, T.L., MacGregor, S., Love, S., Palles, C., Tomlinson, I., Gockel, I., May, A., Gerges, C., Anders, M., Bohmer, A.C., Becker, J., Kreuser, N., Thieme, R., Noder, T., Venerito, M., Veits, L., Schmidt, T., Schmidt, C., Izbicki, J.R., Holscher, A.H., Lang, H., Lorenz, D., Schumacher, B., Mayershofer, R., Vashist, Y., Ott, K., Vieth, M., Weismuller, J., Nothen, M.M., Moebus, S., Knapp, M., Peters, W.H.M., Neuhaus, H., Rosch, T., Ell, C., Jankowski, J., Schumacher, J., Neale, R.E., Whiteman, D.C., & Thrift, A.P. (2019). No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. Clin Gastroenterol Hepatol, 17(11), 2227-35 e1.
  128. Ettinger, D.S., Wood, D.E., Aggarwal, C., Aisner, D.L., Akerley, W., Bauman, J.R., Bharat, A., Bruno, D.S., Chang, J.Y., Chirieac, L.R., D'Amico, T.A., Dilling, T.J., Dobelbower, M., Gettinger, S., Govindan, R., Gubens, M.A., Hennon, M., Horn, L., Lackner, R.P., Lanuti, M., Leal, T.A., Lin, J., Loo, B.W., Martins, R.G., Otterson, G.A., Patel, S.P., Reckamp, K.L., Riely, G.J., Schild, S.E., Shapiro, T.A., Stevenson, J., Swanson, S.J., Tauer, K.W., Yang, S.C., Gregory, K., & Hughes, M. (2019). Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw, 17(12), 1464-72.
  129. Krishna, B.M., Jana, S., Singhal, J., Horne, D., Awasthi, S., Salgia, R., & Singhal, S.S. (2019). Notch signaling in breast cancer: From pathway analysis to therapy. Cancer Lett, 461, 123-31.
  130. Chen, H., Yuan, K., Zhang, B., Jia, Z., Chen, C., Zhu, Y., Sun, Y., Zhou, H., Huang, W., Liang, L., Yan, Q., & Wang, C. (2019). A Novel Compound Heterozygous CYP17A1 Variant Causes 17alpha-Hydroxylase/17, 20-Lyase Deficiency. Front Genet, 10, Article number: 996.
  131. Philip, E.J., Bergerot, C.D., Clark, K., Bergerot, P., & Loscalzo, M. (2019). Obesity and psychosocial well-being among cancer patients and survivors. Psychooncology, 28(11), 2141-8.
  132. Kim, H.-K., Javed, M.R., Chen, S., Zettlitz, K.A., Collins, J., Wu, A.M., Kim, C.-J.C.J., Michael van Dam, R., & Keng, P.Y. (2019). On-demand radiosynthesis of N-succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) on an electrowetting-on-dielectric microfluidic chip for 18F-labeling of protein. RSC Advances, 9(55), 32175-83.
  133. Griffiths, J.I., Cohen, A.L., Jones, V., Salgia, R., Chang, J.T., & Bild, A.H. (2019). Opportunities for improving cancer treatment using systems biology. Current Opinion in Systems Biology, 17, 41-50.
  134. Gockley, A., Melamed, A., Cronin, A., Bookman, M.A., Burger, R.A., Cristae, M.C., Griggs, J.J., Mantia-Smaldone, G., Matulonis, U.A., Meyer, L.A., Niland, J., O'Malley, D.M., & Wright, A.A. (2019). Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer. Am J Obstet Gynecol, 221(6), 625 e1- e14.
  135. Disel, U., Madison, R., Abhishek, K., Chung, J.H., Trabucco, S.E., Matos, A.O., Frampton, G.M., Albacker, L.A., Reddy, V., Karadurmus, N., Benson, A., Webster, J., Paydas, S., Cabanillas, R., Nangia, C., Ozturk, M.A., Millis, S.Z., Pal, S.K., Wilky, B., Sokol, E.S., Gay, L.M., Soman, S., Ganesan, S., Janeway, K., Stephens, P.J., Zhu, V.W., Ou, S.I., Lovly, C.M., Gounder, M., Schrock, A.B., Ross, J.S., Miller, V.A., Klempner, S.J., & Ali, S.M. (2019). The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA. Oncologist.
  136. Buchbinder, D., Patel, S.K., Casillas, J.N., Nugent, D.J., Neudorf, S., Sender, L.S., Torno, L., Huszti, H., Zeltzer, L.K., & Parsons, S.K. (2019). Parent proxy assessment of sibling quality of life following pediatric hematopoietic cell transplantation. Health Qual Life Outcomes, 17, 162.
  137. Tsao, M.S., Carbone, M., Galateau-Salle, F., Moreira, A.L., Nicholson, A.G., Roden, A.C., Adjei, A.A., Aubry, M.C., Fennell, D.A., Gomez, D., Harpole, D., Hesdorffer, M., Hirsch, F.R., Liu, G., Malik, S., Nowak, A., Peikert, T., Salgia, R., Szlosarek, P., Taioli, E., Yang, H., Tsao, A., & Mansfield, A.S. (2019). Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. J Thorac Oncol, 14(10), 1704-17.
  138. Chen, R., Zinzani, P.L., Lee, H.J., Armand, P., Johnson, N.A., Brice, P., Radford, J., Ribrag, V., Molin, D., Vassilakopoulos, T.P., Tomita, A., von Tresckow, B., Shipp, M.A., Lin, J., Kim, E., Nahar, A., Balakumaran, A., & Moskowitz, C.H. (2019). Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087. Blood, 134(14), 1144-53.
  139. Feng, M.Y., Jiang, W., Kim, B.Y.S., Zhang, C.C., Fu, Y.X., & Weissman, I.L. (2019). Phagocytosis checkpoints as new targets for cancer immunotherapy. Nature Reviews Cancer, 19(10), 568-86.
  140. Siddiqi, T., Frankel, P., Beumer, J.H., Kiesel, B.F., Christner, S., Ruel, C., Song, J.Y., Chen, R., Kelly, K.R., Ailawadhi, S., Kaesberg, P., Popplewell, L., Puverel, S., Piekarz, R., Forman, S.J., & Newman, E.M. (2019). Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies. Leuk Lymphoma.
  141. Hida, T., Velcheti, V., Reckamp, K.L., Nokihara, H., Sachdev, P., Kubota, T., Nakada, T., Dutcus, C.E., Ren, M., & Tamura, T. (2019). A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. Lung Cancer, 138, 124-30.
  142. Lee, J.S., Yost, S.E., Blanchard, S., Schmolze, D., Yin, H.H., Pillai, R., Robinson, K., Tang, A., Martinez, N., Portnow, J., Wen, W., Yim, J.H., Brauer, H.A., Ren, Y., Luu, T., Mortimer, J., & Yuan, Y. (2019). Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer. Breast Cancer Res, 21, Article number: 119.
  143. Takebe, N., Beumer, J.H., Kummar, S., Kiesel, B.F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L.K., Vaishampayan, U., Goel, S., O'Bryant, C.L., El-Rayes, B.F., Chung, V., Lenz, H.J., Kim, R., Belani, C.P., Tuscano, J.M., Schelman, W., Moore, N., Doroshow, J.H., & Chen, A.P. (2019). A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Br J Clin Pharmacol, 85(11), 2499-511.
  144. Tuscano, J.M., Maverakis, E., Groshen, S., Tsao-Wei, D., Luxardi, G., Merleev, A.A., Beaven, A., DiPersio, J.F., Popplewell, L., Chen, R., Kirschbaum, M., Schroeder, M.A., & Newman, E.M. (2019). A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma. Clin Cancer Res, 25(23), 7004-13.
  145. Luu, T., Frankel, P., Beumer, J.H., Lim, D., Cristea, M., Appleman, L.J., Lenz, H.J., Gandara, D.R., Kiesel, B.F., Piekarz, R.L., & Newman, E.M. (2019). Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial. Cancer Chemother Pharmacol, 84(6), 1201-8.
  146. Sadeghi, S., Groshen, S.G., Tsao-Wei, D.D., Parikh, R., Mortazavi, A., Dorff, T.B., Kefauver, C., Hoimes, C., Doyle, L., Quinn, D.I., Newman, E., & Lara, P.N., Jr. (2019). Phase II California Cancer Consortium Trial of Gemcitabine-Eribulin Combination in Cisplatin-Ineligible Patients With Metastatic Urothelial Carcinoma: Final Report (NCI-9653). J Clin Oncol, 37(29), 2682-8.
  147. Welsh, J.W., Tang, C., de Groot, P., Naing, A., Hess, K.R., Heymach, J.V., Papadimitrakopoulou, V.A., Cushman, T.R., Subbiah, V., Chang, J.Y., Simon, G.R., Ramapriyan, R., Barsoumian, H.B., Menon, H., Cortez, M.A., Massarelli, E., Nguyen, Q., Sharma, P., Allison, J.P., Diab, A., Verma, V., Raju, U., Shaaban, S.G., Dadu, R., Cabanillas, M.E., Wang, K., Anderson, C., Gomez, D.R., Hahn, S., Komaki, R., & Hong, D.S. (2019). Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Respons. Cancer Immunology Research, 7(12), 1903-9.
  148. Kalvala, A., Wallet, P., Yang, L., Wang, C., Li, H., Nam, A., Nathan, A., Mambetsariev, I., Poroyko, V., Gao, H., Chu, P., Sattler, M., Bild, A., Manuel, E.R., Lee, P.P., Jolly, M.K., Kulkarni, P., & Salgia, R. (2019). Phenotypic Switching of Naive T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS. J Clin Med, 8(10), 1726.
  149. Barasch, A., Li, H., Rajasekhar, V.K., Raber-Durlacher, J., Epstein, J.B., Carroll, J., & Haimovitz-Friedman, A. (2019). Photobiomodulation effects on head and neck squamous cell carcinoma (HNSCC) in an orthotopic animal model. Support Care Cancer.
  150. Hahn, A.W., Pal, S.K., & Agarwal, N. (2019). Potential Roles for PD-1 Inhibition and Cabozantinib in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma. Oncologist, 24.
  151. Sanfilippo, K.M., Luo, S., Wang, T.F., Fiala, M., Schoen, M., Wildes, T.M., Mikhael, J., Kuderer, N.M., Calverley, D.C., Keller, J., Thomas, T., Carson, K.R., & Gage, B.F. (2019). Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol, 94(11), 1176-84.
  152. Wiseman, J.T., Kimbrough, C., Beal, E.W., Zaidi, M.Y., Staley, C.A., Grotz, T., Leiting, J., Fournier, K., Lee, A.J., Dineen, S., Powers, B., Veerapong, J., Baumgartner, J.M., Clarke, C., Patel, S.H., Dhar, V., Hendrix, R.J., Lambert, L., Abbott, D.E., Pokrzywa, C., Raoof, M., Lee, B., Fackche, N., Greer, J., Pawlik, T.M., Abdel-Misih, S., & Cloyd, J.M. (2019). Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol.
  153. Pergam, S.A., Englund, J.A., Kamboj, M., Gans, H.A., Young, J.H., Hill, J.A., Savani, B., Chemaly, R.F., Dadwal, S.S., Storek, J., Duchin, J., & Carpenter, P.A. (2019). Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant, 25(11), e321-e30.
  154. Blakely, A.M., Cohen, J.T., Comissiong, D.S., Vezeridis, M.P., & Miner, T.J. (2019). Prognosis and Management of Thick and Ultrathick Melanoma. Am J Clin Oncol, 42(11), 824-9.
  155. Zhu, L., He, X., Dong, H., Sun, J., Wang, H., Zhu, Y., Huang, F., Zou, J., Chen, Z., Zhao, X., & Li, L. (2019). Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesis. Int J Biol Sci, 15(13), 2763-73.
  156. Dou, L., Yan, F., Pang, J., Zheng, D., Li, D., Gao, L., Wang, L., Xu, Y., Shi, J., Wang, Q., Zhou, L., Shen, N., Singh, P., Wang, L., Li, Y., Gao, Y., Liu, T., Chen, C., Al-Kali, A., Litzow, M.R., Chi, Y.I., Bode, A.M., Liu, C., Huang, H., Liu, D., Marcucci, G., Liu, S., & Yu, L. (2019). Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia. Nat Commun, 10, Article number: 5051.
  157. Gupta, R., Jamal, F., Yang, D., Chendri, C., Aldoss, I., Malki, M.A., Mei, M., Salhotra, A., Dobrin, S., Tran, M., Venkataraman, K., Palmer, J., Stein, A.S., Sandhu, K., Khaled, S., Aribi, A., Marcucci, G., Forman, S.J., Snyder, D., Nakamura, R., Ali, H., & Pullarkat, V. (2019). Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis. Bone Marrow Transplant.
  158. Li, R., & Vora, N. (2019). Radiation Therapy for Surgically Resected Brain Metastasis: What Is Your Approach? Int J Radiat Oncol Biol Phys, 105(5), 938-9.
  159. Shinde, A., Yang, D., Frankel, P., Liu, A., Han, C., Del Vecchio, B., Schultheiss, T., Cheng, J., Li, R., Kim, D., Radany, E.H., Hui, S., Somlo, G., Rosenthal, J., Stein, A., Forman, S., & Wong, J.Y.C. (2019). Radiation-Related Toxicities Using Organ Sparing Total Marrow Irradiation Transplant Conditioning Regimens. Int J Radiat Oncol Biol Phys, 105(5), 1025-33.
  160. Gill, R.R., Tsao, A.S., Kindler, H.L., Richards, W.G., Armato, S.G., 3rd, Francis, R.J., Gomez, D.R., Dahlberg, S., Rimner, A., Simone, C.B., 2nd, de Perrot, M., Blumenthal, G., Adjei, A.A., Bueno, R., Harpole, D.H., Jr., Hesdorffer, M., Hirsch, F.R., Pass, H.I., Yorke, E., Rosenzweig, K., Burt, B., Fennell, D.A., Lindwasser, W., Malik, S., Peikert, T., Mansfield, A.S., Salgia, R., Yang, H., Rusch, V.W., & Nowak, A.K. (2019). Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol, 14(10), 1718-31.
  161. Zuniga, W.C., Jones, V., Anderson, S.M., Echevarria, A., Miller, N.L., Stashko, C., Schmolze, D., Cha, P.D., Kothari, R., Fong, Y., & Storrie-Lombardi, M.C. (2019). Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy. Sci Rep, 9, Article number: 14639.
  162. Yuan, S., Yang, D., Nakamura, R., Zhuang, L., Al Malki, M.M., & Wang, S. (2019). RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation. Transfusion, 59(11), 3371-85.
  163. Lee, T.C., Wima, K., Sussman, J.J., Ahmad, S.A., Cloyd, J.M., Ahmed, A., Fournier, K., Lee, A.J., Dineen, S., Powers, B., Veerapong, J., Baumgartner, J.M., Clarke, C., Mogal, H., Zaidi, M.Y., Maithel, S.K., Leiting, J., Grotz, T., Lambert, L., Hendrix, R.J., Abbott, D.E., Pokrzywa, C., Blakely, A.M., Lee, B., Johnston, F.M., Greer, J., & Patel, S.H. (2019). Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg.
  164. Mitchell, K.A., Shah, E., Bowman, E.D., Zingone, A., Nichols, N., Pine, S.R., Kittles, R.A., & Ryan, B.M. (2019). Relationship between West African ancestry with lung cancer risk and survival in African Americans. Cancer Causes Control, 30(11), 1259-68.
  165. MacKay Helou, S., Gadberry, C., Tran, S., Zahara, N., Talbot, J., Vidhyarkorn, T., Nickols, C., Russell, J., Otap, D., Churchill, S., Estrabaut, M., Piggee, J., & Scher, C. (2019). A relationship-based approach to improving clinical trials: The imCORE research network experience. Contemp Clin Trials, 86, 105861.
  166. Erhunmwunsee, L., Backhus, L.M., Godoy, L., Edwards, M.A., & Cooke, D.T. (2019). Report from the Workforce on Diversity and Inclusion-The Society of Thoracic Surgeons Members' Bias Experiences. Ann Thorac Surg, 108(5), 1287-91.
  167. Hahn, M.A., Jin, S.G., Li, A.X., Liu, J., Huang, Z., Wu, X., Kim, B.W., Johnson, J., Bilbao, A.V., Tao, S., Yim, J.A., Fong, Y., Goebbels, S., Schwab, M.H., Lu, Q., & Pfeifer, G.P. (2019). Reprogramming of DNA methylation at NEUROD2-bound sequences during cortical neuron differentiation. Sci Adv, 5(10), eaax0080.
  168. Von Ah, D., Brown, C.G., Brown, S.J., Bryant, A.L., Davies, M., Dodd, M., Ferrell, B., Hammer, M., Knobf, M.T., Knoop, T.J., LoBiondo-Wood, G., Mayer, D.K., Miaskowski, C., Mitchell, S.A., Song, L., Watkins Bruner, D., Wesmiller, S., & Cooley, M.E. (2019). Research Agenda of the Oncology Nursing Society: 2019-2022. Oncol Nurs Forum, 46(6), 654-69.
  169. Lewis, A., Raoof, M., Ituarte, P.H.G., Williams, J., Melstrom, L., Li, D., Lee, B., & Singh, G. (2019). Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment. Ann Surg, 270(6), 1131-7.
  170. Egelston, C.A., Avalos, C., Tu, T.Y., Rosario, A., Wang, R., Solomon, S., Srinivasan, G., Nelson, M.S., Huang, Y., Lim, M.H., Simons, D.L., He, T.F., Yim, J.H., Kruper, L., Mortimer, J., Yost, S., Guo, W., Ruel, C., Frankel, P.H., Yuan, Y., & Lee, P.P. (2019). Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients. JCI Insight, 4(19), e130000.
  171. Aldoss, I., & Pullarkat, V. (2019). Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1. Leuk Lymphoma, 60(11), 2832-4.
  172. Derman, B.A., Kordas, K., Ridgeway, J., Chow, S., Dale, W., Lee, S.M., Aguada, E., Jakubowiak, A.J., Jasielec, J., Kline, J., Kosuri, S., Larson, R.A., Liu, H.T., Mortel, M., Odenike, O., Pisano, J., Riedell, P., Stock, W., Bishop, M.R., & Artz, A.S. (2019). Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults. Blood Advances, 3(22), 3488-98.
  173. Gangaraju, R., Chen, Y., Hageman, L., Wu, J., Francisco, L., Kung, M., Ness, E., Parman, M., Weisdorf, D.J., Forman, S.J., Arora, M., Armenian, S.H., & Bhatia, S. (2019). Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation. Cancer, 125(24), 4498-508.
  174. Di Raimondo, C., Abdulla, F.R., Zain, J., Querfeld, C., & Rosen, S.T. (2019). Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Br J Haematol, 187(3), e79-e82.
  175. Grizzle, W.E., Kittles, R.A., Rais-Bahrami, S., Shah, E., Adams, G.W., DeGuenther, M.S., Kolettis, P.N., Nix, J.W., Bryant, J.E., Chinsky, R., Kearns, J.E., Dehimer, K., Terrin, N., Chang, H., & Gaston, S.M. (2019). Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy. Cancer Med, 8(16), 6915-22.
  176. Zhang, Y., Qu, M., Yi, X., Zhuo, P., Tang, J., Chen, X., Zhou, G., Hu, P., Qiu, T., Xing, W., Mao, Y., Chen, B.T., Wu, J., Zhang, Y., & Liao, W. (2019). Sensorimotor and pain-related alterations of the gray matter and white matter in Type 2 diabetic patients with peripheral neuropathy. Hum Brain Mapp.
  177. Ochsner, S.A., Abraham, D., Martin, K., Ding, W., McOwiti, A., Kankanamge, W., Wang, Z., Andreano, K., Hamilton, R.A., Chen, Y., Hamilton, A., Gantner, M.L., Dehart, M., Qu, S., Hilsenbeck, S.G., Becnel, L.B., Bridges, D., Ma'ayan, A., Huss, J.M., Stossi, F., Foulds, C.E., Kralli, A., McDonnell, D.P., & McKenna, N.J. (2019). The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways. Sci Data, 6, Article number: 252.
  178. Lennon, K.M., Wakefield, D.L., Maddox, A.L., Brehove, M.S., Willner, A.N., Garcia-Mansfield, K., Meechoovet, B., Reiman, R., Hutchins, E., Miller, M.M., Goel, A., Pirrotte, P., Van Keuren-Jensen, K., & Jovanovic-Talisman, T. (2019). Single molecule characterization of individual extracellular vesicles from pancreatic cancer. J Extracell Vesicles, 8(1), Article number: 1685634.
  179. Kanaya, N., Chang, G., Wu, X., Saeki, K., Bernal, L., Shim, H.J., Wang, J., Warden, C., Yamamoto, T., Li, J., Park, J.S., Synold, T., Vonderfecht, S., Rakoff, M., Neuhausen, S.L., & Chen, S. (2019). Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary gland. Commun Biol, 2, 406.
  180. Carroll, J.E., Small, B.J., Tometich, D.B., Zhai, W., Zhou, X., Luta, G., Ahles, T.A., Saykin, A.J., Nudelman, K.N.H., Clapp, J.D., Jim, H.S., Jacobsen, P.B., Hurria, A., Graham, D., McDonald, B.C., Denduluri, N., Extermann, M., Isaacs, C., Dilawari, A.A., Root, J., Stern, R.A., Mandelblatt, J.S., Thinking, & Living With Cancer Study. (2019). Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype. Cancer, 125(24), 4516-24.
  181. Villani, V., Thornton, M.E., Zook, H.N., Crook, C.J., Grubbs, B.H., Orlando, G., De Filippo, R., Ku, H.T., & Perin, L. (2019). SOX9+/PTF1A+ Cells Define the Tip Progenitor Cells of the Human Fetal Pancreas of the Second Trimester. Stem Cells Transl Med, 8(12), 1249-64.
  182. Abdel-Azim, H., Sun, W., & Wu, L. (2019). Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy. Pharmacol Ther, 204, 107403.
  183. Bhatia, S., Chen, Y., Wong, F.L., Hageman, L., Smith, K., Korf, B., Cannon, A., Leidy, D.J., Paz, A., Andress, J.E., Friedman, G.K., Metrock, K., Neglia, J.P., Arnold, M., Turcotte, L.M., de Blank, P., Leisenring, W., Armstrong, G.T., Robison, L.L., Clapp, D.W., Shannon, K., Nakamura, J.L., & Fisher, M.J. (2019). Subsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1. J Clin Oncol, 37(32), 3050-8.
  184. Pacheco, L.S., Anderson, C.A.M., Lacey, J.V., Jr., Giovannucci, E.L., Lemus, H., Araneta, M.R.G., Sears, D.D., Talavera, G.A., & Martinez, M.E. (2019). Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study. PLoS One, 14(10), e0223638.
  185. Limchantra, I.V., Fong, Y.M., & Melstrom, K.A. (2019). Surgical Smoke Exposure in Operating Room Personnel A Review. Jama Surgery, 154(10), 960-7.
  186. Fan, J., Zhang, W., Gao, W., Wang, T., Duan, W.L., Liang, Y., & Zhang, Z. (2019). Syntheses of Benzofuranoquinolines and Analogues via Photoinduced Acceptorless Dehydrogenative Annulation of o-Phenylfuranylpyridines. Org Lett, 21(22), 9183-7.
  187. Ramachandran, I., Lowther, D.E., Dryer-Minnerly, R., Wang, R., Fayngerts, S., Nunez, D., Betts, G., Bath, N., Tipping, A.J., Melchiori, L., Navenot, J.M., Glod, J., Mackall, C.L., D'Angelo, S.P., Araujo, D.M., Chow, W.A., Demetri, G.D., Druta, M., Van Tine, B.A., Grupp, S.A., Abdul Razak, A.R., Wilky, B., Iyengar, M., Trivedi, T., Winkle, E.V., Chagin, K., Amado, R., Binder, G.K., & Basu, S. (2019). Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma. J Immunother Cancer, 7, Article number: 276.
  188. Villamizar, O., Waters, S.A., Scott, T., Saayman, S., Grepo, N., Urak, R., Davis, A., Jaffe, A., & Morris, K.V. (2019). Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator. Mol Ther, 27(10), 1737-48.
  189. Yoon, S., Huang, K.W., Andrikakou, P., Vasconcelos, D., Swiderski, P., Reebye, V., Sodergren, M., Habib, N., & Rossi, J.J. (2019). Targeted Delivery of C/EBPalpha-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Mol Ther Nucleic Acids, 18, 142-54.
  190. Casadei, C., Dizman, N., Schepisi, G., Cursano, M.C., Basso, U., Santini, D., Pal, S.K., & De Giorgi, U. (2019). Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors. Ther Adv Med Oncol, 11, 1758835919890285.
  191. Zhu, Y., He, X., Lin, Y.C., Dong, H., Zhang, L., Chen, X., Wang, Z., Shen, Y., Li, M., Wang, H., Sun, J., Nguyen, L.X., Zhang, H., Jiang, W., Yang, Y., Chen, J., Muschen, M., Chen, C.W., Konopleva, M.Y., Sun, W., Jin, J., Carlesso, N., Marcucci, G., Luo, Y., & Li, L. (2019). Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia. Blood, 134(15), 1257-68.
  192. Shouse, G., & Nikolaenko, L. (2019). Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders. Curr Hematol Malig Rep, 14(6), 570-6.
  193. Epstein, J.B., Silva, S., Epstein, G.L., Leal, J.H.S., Barasch, A., & Smutzer, G. (2019). Taste disorders following cancer treatment: report of a case series. Support Care Cancer, 27(12), 4587-95.
  194. Xu, Y.J., Khan, S., Didier, A.C., Wozniak, M., Liu, Y., Singh, A., & Nakamura, T.M. (2019). A tel2 Mutation That Destabilizes the Tel2-Tti1-Tti2 Complex Eliminates Rad3(ATR) Kinase Signaling in the DNA Replication Checkpoint and Leads to Telomere Shortening in Fission Yeast. Mol Cell Biol, 39(20), Article number: e00175-19.
  195. Gilligan, T., Lin, D.W., Aggarwal, R., Chism, D., Cost, N., Derweesh, I.H., Emamekhoo, H., Feldman, D.R., Geynisman, D.M., Hancock, S.L., LaGrange, C., Levine, E.G., Longo, T., Lowrance, W., McGregor, B., Monk, P., Picus, J., Pierorazio, P., Rais-Bahrami, S., Saylor, P., Sircar, K., Smith, D.C., Tzou, K., Vaena, D., Vaughn, D., Yamoah, K., Yamzon, J., Johnson-Chilla, A., Keller, J., & Pluchino, L.A. (2019). Testicular Cancer, Version 2.2020. J Natl Compr Canc Netw, 17(12), 1529-54.
  196. Rodriguez, S., Abundis, C., Boccalatte, F., Mehrotra, P., Chiang, M.Y., Yui, M.A., Wang, L., Zhang, H., Zollman, A., Bonfim-Silva, R., Kloetgen, A., Palmer, J., Sandusky, G., Wunderlich, M., Kaplan, M.H., Mulloy, J.C., Marcucci, G., Aifantis, I., Cardoso, A.A., & Carlesso, N. (2019). Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia.
  197. Bose, C., Singh, S.P., Igid, H., Green, W.C., Singhal, S.S., Lee, J., Palade, P.T., Rajan, A., Ball, S., Tonk, V., Hindle, A., Tarbox, M., & Awasthi, S. (2019). Topical 2'-Hydroxyflavanone for Cutaneous Melanoma. Cancers (Basel), 11(10), 1556.
  198. Jabbour, E.J., G?kbuget, N., Kantarjian, H.M., Thomas, X., Larson, R.A., Yoon, S.S., Ghobadi, A., Topp, M.S., Tran, Q., Franklin, J.L., Forman, S.J., & Stein, A.S. (2019). Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Cancer, 125(23), 4181-92.
  199. Kang, Y., Zhang, W., Wang, T., Liang, Y., & Zhang, Z. (2019). Two-Step Synthesis of pi-Expanded Maleimides from 3,4-Diphenylfuran-2(5H)-ones. J Org Chem, 84(19), 12387-98.
  200. Lunning, M., Vose, J., Nastoupil, L., Fowler, N., Burger, J.A., Wierda, W.G., Schreeder, M.T., Siddiqi, T., Flowers, C.R., Cohen, J.B., Sportelli, P., Miskin, H.P., Weiss, M.S., & O'Brien, S. (2019). Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood, 134(21), 1811-20.
  201. Johnston, B.C., Zeraatkar, D., Han, M.A., Vernooij, R.W.M., Valli, C., El Dib, R., Marshall, C., Stover, P.J., Fairweather-Taitt, S., Wojcik, G., Bhatia, F., de Souza, R., Brotons, C., Meerpohl, J.J., Patel, C.J., Djulbegovic, B., Alonso-Coello, P., Bala, M.M., & Guyatt, G.H. (2019). Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med, 171(10), 756-64.
  202. Marzagalli, M., Ebelt, N.D., & Manuel, E.R. (2019). Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin Cancer Biol, 59, 236-50.
  203. Gonzalez, L., & Kruper, L. (2019). Updates in Genetic Testing Guidelines for Breast Cancer Susceptibility Genes: a Change in the Paradigm. Curr Breast Cancer Rep, 11(4), 358-64.
  204. Chaudhry, A.A., Naim, S., Gul, M., Chaudhry, A., Chen, M., Jandial, R., & Badie, B. (2019). Utility of Preoperative Blood-Oxygen-Level-Dependent Functional MR Imaging in Patients with a Central Nervous System Neoplasm. Radiol Clin North Am, 57(6), 1189-98.
  205. Wong, F.L., Stiller, T., Obenchain, R., David, C., Patel, S.K., Xie, B., Loscalzo, M., & Clark, K. (2019). Validation of a biopsychosocial distress screening tool, "You, Your Family and COH Are a Team". Psychooncology, 28(12), 2396-405.
  206. Willis, J., Lefterova, M.I., Artyomenko, A., Kasi, P.M., Nakamura, Y., Mody, K., Catenacci, D.V.T., Fakih, M., Barbacioru, C., Zhao, J., Sikora, M., Fairclough, S.R., Lee, H., Kim, K.M., Kim, S.T., Kim, J., Gavino, D., Benavides, M., Peled, N., Nguyen, T., Cusnir, M., Eskander, R.N., Azzi, G., Yoshino, T., Banks, K.C., Raymond, V.M., Lanman, R.B., Chudova, D.I., Talasaz, A., Kopetz, S., Lee, J., & Odegaard, J.I. (2019). Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel. Clin Cancer Res, 25(23), 7035-45.
  207. Aldoss, I., Zhang, J., Pillai, R., Shouse, G., Sanchez, J.F., Mei, M., Nakamura, R., Stein, A.S., Forman, S.J., Marcucci, G., & Pullarkat, V. (2019). Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia. Br J Haematol, 187(2), e45-e8.
  208. Gangaraju, R., Chen, Y., Hageman, L., Wu, J., Francisco, L., Battles, K., Kung, M., Ness, E., Parman, M., Weisdorf, D.J., Forman, S.J., Arora, M., Armenian, S.H., & Bhatia, S. (2019). Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study. Biol Blood Marrow Transplant, 25(11), 2261-6.
  209. Finlay, J.B., & Buehler, A. (2019). You know what happens when you assume. Lab Anim (NY), 48(11), 318-9.